Vanderbilt University Medical Center (VUMC) has established a program known as PREDICT (Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment). In this issue, [Peterson et al.] describe the successful integration of genomic information to help guide decisions about prescription drug choices.
How will patients be involved in decisions about their genomic information? [Hazin et al doi: GIM.2013.117.] explore issues related to patients' needs to have equitable access to genetic testing. The authors explore the need for accessible educational materials, as well as how to share information, balancing privacy and security, and suggest potential policy solutions.
What does the future hold for the integration of genomic information into the EHR? Changing physician behavior and improving care requires Genomic Decision Support(GDS). [citation: Overby et al doi: GIM.2013.128] GDS uses genomic results to provide physicians with recommendations and suggested actions to take at the point of care. In their closing commentary [citation: ] Drs. Kannry and Williams note "that within the next few years, we will see researchers develop external CDS(Clinical Decision Support) capable of generating messages that trigger specific actionable items in a commercial EHR. Until standard representation of genomic results occurs, widespread adaptation of CDS by commercial EHRs will continue to be challenging regardless of value propositions by providers and patients."
"If we believe that there is information in the genome that is going to lead to more effective and safer therapies, we need to solve these issues," said Williams. "We are basically trying to build a bridge over a canyon, and you can't leave out any of the key structural elements and expect the bridge to hold together. We really need to solve these problems if we want to move to what some people are cal
|Contact: Kathy Ridgely Beal|
American College of Medical Genetics